Starling Oncology TOI Stock
Starling Oncology Price Chart
Starling Oncology TOI Financial and Trading Overview
| Starling Oncology stock price | 5.13 USD |
| Previous Close | 0 USD |
| Open | 4.93 USD |
| Bid | 3.68 USD x 200 |
| Ask | 6.31 USD x 200 |
| Day's Range | 4.87 - 5.15 USD |
| 52 Week Range | 2.32 - 7.05 USD |
| Volume | 1.21M USD |
| Avg. Volume | 1.99M USD |
| Market Cap | 512.91M USD |
| Beta (5Y Monthly) | 0.422 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.35 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.4 USD |
TOI Valuation Measures
| Enterprise Value | 587.55M USD |
| Trailing P/E | N/A |
| Forward P/E | -32.0625 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.9398064 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.077 |
| Enterprise Value/EBITDA | -22.677 |
Trading Information
Starling Oncology Stock Price History
| Beta (5Y Monthly) | 0.422 |
| 52-Week Change | 51.21% |
| S&P500 52-Week Change | 18.67% |
| 52 Week High | 7.05 USD |
| 52 Week Low | 2.32 USD |
| 50-Day Moving Average | 5.31 USD |
| 200-Day Moving Average | 3.87 USD |
TOI Share Statistics
| Avg. Volume (3 month) | 1.99M USD |
| Avg. Daily Volume (10-Days) | 1.97M USD |
| Shares Outstanding | 99.98M |
| Float | 86.67M |
| Short Ratio | 3.29 |
| % Held by Insiders | 18.41% |
| % Held by Institutions | 46.04% |
| Shares Short | 7.27M |
| Short % of Float | 8.30% |
| Short % of Shares Outstanding | 7.27% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | NaN |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -7.97% |
| Operating Margin (ttm) | -4.41% |
| Gross Margin | 15.11% |
| EBITDA Margin | -4.74% |
Management Effectiveness
| Return on Assets (ttm) | -12.29% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 545.76M USD |
| Revenue Per Share (ttm) | 5.54 USD |
| Quarterly Revenue Growth (yoy) | 41.19% |
| Gross Profit (ttm) | 82.5M USD |
| EBITDA | -25909000 USD |
| Net Income Avi to Common (ttm) | -36324000 USD |
| Diluted EPS (ttm) | -0.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 30.28M USD |
| Total Cash Per Share (mrq) | 0.3 USD |
| Total Debt (mrq) | 104.91M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.473 |
| Book Value Per Share (mrq) | -0.163 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -21814000 USD |
| Levered Free Cash Flow (ttm) | -15312625 USD |
Profile of Starling Oncology
| Country | United States |
| State | CA |
| City | Cerritos |
| Address | 18000 Studebaker Road |
| ZIP | 90703 |
| Phone | 562 735 3226 |
| Website | https://theoncologyinstitute.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | 641 |
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Q&A For Starling Oncology Stock
What is a current TOI stock price?
Starling Oncology TOI stock price today per share is 5.13 USD.
How to purchase Starling Oncology stock?
You can buy TOI shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Starling Oncology?
The stock symbol or ticker of Starling Oncology is TOI.
Which industry does the Starling Oncology company belong to?
The Starling Oncology industry is Medical Care Facilities.
How many shares does Starling Oncology have in circulation?
The max supply of Starling Oncology shares is 99.98M.
What is Starling Oncology Price to Earnings Ratio (PE Ratio)?
Starling Oncology PE Ratio is now.
What was Starling Oncology earnings per share over the trailing 12 months (TTM)?
Starling Oncology EPS is -0.35 USD over the trailing 12 months.
Which sector does the Starling Oncology company belong to?
The Starling Oncology sector is Healthcare.
Starling Oncology TOI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26180.46 USD — |
+0.43
|
6.32B USD — | 26049.3 USD — | 26269.85 USD — | — - | 6.32B USD — |
|
US Tech Health Care
IXHC
US
|
1367.82 USD — |
+1.36
|
— — | 1351.7 USD — | 1374.29 USD — | — - | — — |
- {{ link.label }} {{link}}
